Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDImmunic Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 7 | -$1.26 | -$0.19 | -$0.69 |
| Q2 2026 | 8 | -$2.26 | -$0.59 | -$1.16 |
| Q3 2026 | 8 | -$1.44 | -$0.81 | -$0.98 |
| Q4 2026 | 9 | -$1.30 | -$0.53 | -$0.81 |
| Q1 2027 | 6 | -$0.61 | -$0.61 | -$0.61 |
| Q2 2027 | 3 | -$0.63 | -$0.63 | -$0.63 |
| Q3 2027 | 3 | -$0.59 | -$0.59 | -$0.59 |
| Q4 2027 | 6 | -$0.64 | -$0.64 | -$0.64 |
| Q1 2028 | 8 | $0.83 | $0.83 | $0.83 |
| Q2 2028 | 4 | $1.53 | $1.53 | $1.53 |
| Q3 2028 | 5 | $1.50 | $1.50 | $1.50 |
| Q4 2028 | 8 | $1.53 | $1.53 | $1.53 |
Immunic Inc Earnings Date And Information
Immunic Inc last posted its earnings results on Tuesday, August 11th, 2026. The company reported $-0.8 earnings per share for the quarter, topping analysts' consensus estimates of $-1.16 by $0.36. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Immunic Inc has generated $-6 earnings per share over the last year ($-6.24 diluted earnings per share) and currently has a price-to-earnings ratio of -3.44. Immunic Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Immunic Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/11/2026 | Q2 2026 | -$1.16 | -$0.80 | 0.36 | $0 | $0 |
| 05/13/2026 | Q1 2026 | -$0.71 | -$1.08 | -0.37 | $0 | $0 |
| 02/26/2026 | Q4 2025 | -$0.90 | -$1.60 | -0.7 | $0 | $0 |
| 11/13/2025 | Q3 2025 | -$0.18 | -$1.32 | -1.14 | $0 | $0 |
| 08/07/2025 | Q2 2025 | -$1.58 | -$2.03 | -0.45 | N/A | $0 |
| 05/15/2025 | Q1 2025 | -$2.50 | -$2.51 | -0.01 | N/A | $0 |
| 03/31/2025 | Q4 2024 | N/A | -$2.79 | N/A | $6.00 K | $0 |
| 11/07/2024 | Q3 2024 | -$2.20 | -$2.41 | -0.21 | $6.00 K | $0 |
| 08/08/2024 | Q2 2024 | -$0.23 | -$2.11 | -1.88 | N/A | $0 |
| 05/08/2024 | Q1 2024 | -$0.27 | -$3.04 | -2.77 | N/A | $0 |
| 02/22/2024 | Q4 2023 | -$0.51 | -$4.83 | -4.32 | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$5.11 | N/A | N/A | $0 |
| 08/03/2023 | Q2 2023 | -$0.53 | -$5.40 | -4.88 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.52 | -$5.79 | -5.27 | N/A | $0 |
| 02/23/2023 | Q4 2022 | -$0.82 | -$16.28 | -15.46 | N/A | $0 |
| 11/03/2022 | Q3 2022 | -$0.67 | -$6.94 | -6.27 | N/A | $0 |
| 08/04/2022 | Q2 2022 | -$0.73 | -$7.24 | -6.51 | N/A | $0 |
| 05/10/2022 | Q1 2022 | -$0.81 | -$7.40 | -6.59 | N/A | $0 |
| 02/24/2022 | Q4 2021 | -$0.77 | -$8.04 | -7.27 | N/A | $0 |
| 11/04/2021 | Q3 2021 | -$8.10 | -$7.62 | 0.48 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Immunic Inc Earnings: FAQ's
In the previous quarter, Immunic Inc (:IMUX) reported $-0.8 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.16 by $0.36.
The conference call for Immunic Inc's latest earnings report can be listened to online.
The conference call transcript for Immunic Inc's latest earnings report can be read online.
Immunic Inc (:IMUX) has a recorded net income of $-97,172,000.Immunic Inc has generated $-6.24 earnings per share over the last four quarters.
Immunic Inc (:IMUX) has a price-to-earnings ratio of -3.44 and price/earnings-to-growth ratio is -0.04.